Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | 63,724 | reported | 16 May 2025 | tx 1+63,724 |
| Tekla Healthcare Opportunities Fund | 1,148.19 | reported | 09 Apr 2024 | tx 3+1,148.19 |
| H&Q LIFE SCIENCES INVESTORS | 1,085.31 | reported | 09 Apr 2024 | tx 3+1,085.31 |
| H&Q HEALTHCARE INVESTORS | 1,079.53 | reported | 09 Apr 2024 | tx 3+1,079.53 |
| Tekla World Healthcare Fund |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 12 buys in history.
| 1,017.38 |
| reported |
| 09 Apr 2024 |
| tx 3+1,017.38 |
1 purchase reported after at least 12 months of silence — most recent on 09 Apr 2024.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 May 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 63,724 | 0.00 USD | deriv |
| 09 Apr 2024 | PURCHASE | H&Q HEALTHCARE INVESTORS | 525 | 16.42 USD | |
| 09 Apr 2024 | PURCHASE | Tekla World Healthcare Fund | 200 | 12.53 USD | |
| 09 Apr 2024 | PURCHASE | H&Q LIFE SCIENCES INVESTORS | 400 | 13.32 USD | first after silence |
| 09 Apr 2024 | PURCHASE | Tekla Healthcare Opportunities Fund | 600 | 19.54 USD | |
| 23 Mar 2022 | PURCHASE | Tekla World Healthcare Fund | 103.38 | 14.52 USD | |
| 23 Mar 2022 | PURCHASE | H&Q HEALTHCARE INVESTORS | 73.53 | 20.42 USD | |
| 23 Mar 2022 | PURCHASE | H&Q LIFE SCIENCES INVESTORS | 92.31 | 16.27 USD | |
| 23 Mar 2022 | PURCHASE | Tekla Healthcare Opportunities Fund | 69.19 | 21.69 USD | |
| 26 Jan 2022 | PURCHASE | Tekla World Healthcare Fund | 714 | 14.60 USD | |
| 26 Jan 2022 | PURCHASE | H&Q HEALTHCARE INVESTORS | 481 | 21.52 USD | |
| 26 Jan 2022 | PURCHASE | Tekla Healthcare Opportunities Fund | 479 | 21.73 USD | |
| 26 Jan 2022 | PURCHASE | H&Q LIFE SCIENCES INVESTORS | 593 | 17.54 USD |